Preoperative Prediction Model for Early Recurrence of Intrahepatic Cholangiocarcinoma after Surgical Resection: Development and External Validation Study

Purpose We aimed to develop a preoperative risk scoring system to predict early recurrence (ER) of intrahepatic cholangiocarcinoma (ICCA) after resection, utilizing clinical and computed tomography (CT) features.Materials and Methods This multicenter study included 365 patients who underwent curativ...

Full description

Saved in:
Bibliographic Details
Published inCancer research and treatment Vol. 57; no. 4; pp. 1156 - 1166
Main Authors Kim, Dong Hwan, Choi, Sang Hyun, Kim, Sehee, Rhee, Hyungjin, Cho, Eun-Suk, Yeom, Suk-Keu, Park, Sumi, Lee, Seung Soo, Park, Mi-Suk
Format Journal Article
LanguageEnglish
Published Korea (South) 대한암학회 01.10.2025
Subjects
Online AccessGet full text
ISSN1598-2998
2005-9256
2005-9256
DOI10.4143/crt.2024.1187

Cover

Abstract Purpose We aimed to develop a preoperative risk scoring system to predict early recurrence (ER) of intrahepatic cholangiocarcinoma (ICCA) after resection, utilizing clinical and computed tomography (CT) features.Materials and Methods This multicenter study included 365 patients who underwent curative-intent surgical resection for ICCA at six institutions between 2009 and 2016. Of these, 264 patients from one institution constituted the development cohort, while 101 patients from the other institutions constituted the external validation cohort. Logistic regression models were constructed to predict ER based on preoperative variables and were subsequently translated into a risk scoring system. The discrimination performance of the risk scoring system was validated using external data and compared to the American Joint Committee on Cancer (AJCC) TNM staging system.Results Among the 365 patients (mean age, 62±10 years), 153 had ER. A preoperative risk scoring system that incorporated both clinical and CT features demonstrated superior discriminatory performance compared to the postoperative AJCC TNM staging system in both the development (area under the curve [AUC], 0.78 vs. 0.68; p=0.002) and validation cohorts (AUC, 0.69 vs. 0.66; p=0.641). The preoperative risk scoring system effectively stratified patients based on their risk for ER: the 1-year recurrence-free survival rates for the low, intermediate, and high-risk groups were 85.5%, 56.6%, and 15.6%, respectively (p < 0.001) in the development cohort, and 87.5%, 58.5%, and 25.0%, respectively (p < 0.001) in the validation cohort.Conclusion A preoperative risk scoring system that incorporates clinical and CT imaging features was valuable in identifying high-risk patients with ICCA for ER following resection.
AbstractList We aimed to develop a preoperative risk scoring system to predict early recurrence (ER) of intrahepatic cholangiocarcinoma (ICCA) after resection, utilizing clinical and computed tomography (CT) features.PurposeWe aimed to develop a preoperative risk scoring system to predict early recurrence (ER) of intrahepatic cholangiocarcinoma (ICCA) after resection, utilizing clinical and computed tomography (CT) features.This multicenter study included 365 patients who underwent curative-intent surgical resection for ICCA at six institutions between 2009 and 2016. Of these, 264 patients from one institution constituted the development cohort, while 101 patients from the other institutions constituted the external validation cohort. Logistic regression models were constructed to predict ER based on preoperative variables and were subsequently translated into a risk-scoring system. The discrimination performance of the risk-scoring system was validated using external data and compared to the American Joint Committee on Cancer (AJCC) TNM staging system.Materials and MethodsThis multicenter study included 365 patients who underwent curative-intent surgical resection for ICCA at six institutions between 2009 and 2016. Of these, 264 patients from one institution constituted the development cohort, while 101 patients from the other institutions constituted the external validation cohort. Logistic regression models were constructed to predict ER based on preoperative variables and were subsequently translated into a risk-scoring system. The discrimination performance of the risk-scoring system was validated using external data and compared to the American Joint Committee on Cancer (AJCC) TNM staging system.Among the 365 patients (mean age, 62±10 years), 153 had ER. A preoperative risk scoring system that incorporated both clinical and CT features demonstrated superior discriminatory performance compared to the postoperative AJCC TNM staging system in both the development (area under the curve [AUC], 0.78 vs. 0.68; p=0.002) and validation cohorts (AUC, 0.69 vs. 0.66; p=0.641). The preoperative risk scoring system effectively stratified patients based on their risk for ER: the 1-year recurrence-free survival rates for the low, intermediate, and high-risk groups were 85.5%, 56.6%, and 15.6%, respectively (p<0.001) in the development cohort, and 87.5%, 58.5%, and 25.0%, respectively (p<0.001) in the validation cohort.ResultsAmong the 365 patients (mean age, 62±10 years), 153 had ER. A preoperative risk scoring system that incorporated both clinical and CT features demonstrated superior discriminatory performance compared to the postoperative AJCC TNM staging system in both the development (area under the curve [AUC], 0.78 vs. 0.68; p=0.002) and validation cohorts (AUC, 0.69 vs. 0.66; p=0.641). The preoperative risk scoring system effectively stratified patients based on their risk for ER: the 1-year recurrence-free survival rates for the low, intermediate, and high-risk groups were 85.5%, 56.6%, and 15.6%, respectively (p<0.001) in the development cohort, and 87.5%, 58.5%, and 25.0%, respectively (p<0.001) in the validation cohort.A preoperative risk scoring system that incorporates clinical and CT imaging features was valuable in identifying high-risk patients with ICCA for ER following resection.ConclusionA preoperative risk scoring system that incorporates clinical and CT imaging features was valuable in identifying high-risk patients with ICCA for ER following resection.
We aimed to develop a preoperative risk scoring system to predict early recurrence (ER) of intrahepatic cholangiocarcinoma (ICCA) after resection, utilizing clinical and computed tomography (CT) features. This multicenter study included 365 patients who underwent curative-intent surgical resection for ICCA at six institutions between 2009 and 2016. Of these, 264 patients from one institution constituted the development cohort, while 101 patients from the other institutions constituted the external validation cohort. Logistic regression models were constructed to predict ER based on preoperative variables and were subsequently translated into a risk scoring system. The discrimination performance of the risk scoring system was validated using external data and compared to the American Joint Committee on Cancer (AJCC) TNM staging system. Among the 365 patients (mean age, 62±10 years), 153 had ER. A preoperative risk scoring system that incorporated both clinical and CT features demonstrated superior discriminatory performance compared to the postoperative AJCC TNM staging system in both the development (area under the curve [AUC], 0.78 vs. 0.68; p=0.002) and validation cohorts (AUC, 0.69 vs. 0.66; p=0.641). The preoperative risk scoring system effectively stratified patients based on their risk for ER: the 1-year recurrence-free survival rates for the low, intermediate, and high-risk groups were 85.5%, 56.6%, and 15.6%, respectively (p < 0.001) in the development cohort, and 87.5%, 58.5%, and 25.0%, respectively (p < 0.001) in the validation cohort. A preoperative risk scoring system that incorporates clinical and CT imaging features was valuable in identifying high-risk patients with ICCA for ER following resection.
Purpose We aimed to develop a preoperative risk scoring system to predict early recurrence (ER) of intrahepatic cholangiocarcinoma (ICCA) after resection, utilizing clinical and computed tomography (CT) features.Materials and Methods This multicenter study included 365 patients who underwent curative-intent surgical resection for ICCA at six institutions between 2009 and 2016. Of these, 264 patients from one institution constituted the development cohort, while 101 patients from the other institutions constituted the external validation cohort. Logistic regression models were constructed to predict ER based on preoperative variables and were subsequently translated into a risk scoring system. The discrimination performance of the risk scoring system was validated using external data and compared to the American Joint Committee on Cancer (AJCC) TNM staging system.Results Among the 365 patients (mean age, 62±10 years), 153 had ER. A preoperative risk scoring system that incorporated both clinical and CT features demonstrated superior discriminatory performance compared to the postoperative AJCC TNM staging system in both the development (area under the curve [AUC], 0.78 vs. 0.68; p=0.002) and validation cohorts (AUC, 0.69 vs. 0.66; p=0.641). The preoperative risk scoring system effectively stratified patients based on their risk for ER: the 1-year recurrence-free survival rates for the low, intermediate, and high-risk groups were 85.5%, 56.6%, and 15.6%, respectively (p < 0.001) in the development cohort, and 87.5%, 58.5%, and 25.0%, respectively (p < 0.001) in the validation cohort.Conclusion A preoperative risk scoring system that incorporates clinical and CT imaging features was valuable in identifying high-risk patients with ICCA for ER following resection.
Purpose We aimed to develop a preoperative risk scoring system to predict early recurrence (ER) of intrahepatic cholangiocarcinoma (ICCA) after resection, utilizing clinical and computed tomography (CT) features.Materials and Methods This multicenter study included 365 patients who underwent curative-intent surgical resection for ICCA at six institutions between 2009 and 2016. Of these, 264 patients from one institution constituted the development cohort, while 101 patients from the other institutions constituted the external validation cohort. Logistic regression models were constructed to predict ER based on preoperative variables and were subsequently translated into a risk scoring system. The discrimination performance of the risk scoring system was validated using external data and compared to the American Joint Committee on Cancer (AJCC) TNM staging system.Results Among the 365 patients (mean age, 62±10 years), 153 had ER. A preoperative risk scoring system that incorporated both clinical and CT features demonstrated superior discriminatory performance compared to the postoperative AJCC TNM staging system in both the development (area under the curve [AUC], 0.78 vs. 0.68; p=0.002) and validation cohorts (AUC, 0.69 vs. 0.66; p=0.641). The preoperative risk scoring system effectively stratified patients based on their risk for ER: the 1-year recurrence-free survival rates for the low, intermediate, and high-risk groups were 85.5%, 56.6%, and 15.6%, respectively (p < 0.001) in the development cohort, and 87.5%, 58.5%, and 25.0%, respectively (p < 0.001) in the validation cohort.Conclusion A preoperative risk scoring system that incorporates clinical and CT imaging features was valuable in identifying high-risk patients with ICCA for ER following resection. KCI Citation Count: 0
Author Park, Mi-Suk
Rhee, Hyungjin
Lee, Seung Soo
Kim, Sehee
Choi, Sang Hyun
Yeom, Suk-Keu
Kim, Dong Hwan
Cho, Eun-Suk
Park, Sumi
Author_xml – sequence: 1
  givenname: Dong Hwan
  orcidid: 0000-0002-2932-2367
  surname: Kim
  fullname: Kim, Dong Hwan
– sequence: 2
  givenname: Sang Hyun
  orcidid: 0000-0002-6898-6617
  surname: Choi
  fullname: Choi, Sang Hyun
– sequence: 3
  givenname: Sehee
  surname: Kim
  fullname: Kim, Sehee
– sequence: 4
  givenname: Hyungjin
  surname: Rhee
  fullname: Rhee, Hyungjin
– sequence: 5
  givenname: Eun-Suk
  surname: Cho
  fullname: Cho, Eun-Suk
– sequence: 6
  givenname: Suk-Keu
  surname: Yeom
  fullname: Yeom, Suk-Keu
– sequence: 7
  givenname: Sumi
  surname: Park
  fullname: Park, Sumi
– sequence: 8
  givenname: Seung Soo
  surname: Lee
  fullname: Lee, Seung Soo
– sequence: 9
  givenname: Mi-Suk
  surname: Park
  fullname: Park, Mi-Suk
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39930855$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART003254043$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNqFkcFu1DAQhi1URLeFI1fkI0LKEjuOk3CrlgVWKgK1has1ccZbU8dOnaSwj8Lb4t0tXJEsjSx9_z_SfGfkxAePhLxk-VIwUbzVcVrynIslY3X1hCx4npdZw0t5QhasbOqMN019Ss7G8UeeS1FU7Bk5LZqmyOuyXJDfXyOGASNM9gFp-nRWTzZ4-jl06KgJka4huh29Qj3HiF4jDYZu_BThFocU03R1Gxz4rQ0aorY-9EDBTBjp9Ry3VoNL4REPte_oe3xAF4Ye_UTBd3T9K5E-Md_B2Q4Ou6-nuds9J08NuBFfPM5z8u3D-mb1Kbv88nGzurjMNBd5lUHDO1Y3JRpTGaMlb7UwFaBBxjtZt0zUwvCyZQ12soJWYGF0JfePtbJoi3Py5tjro1F32qoA9jC3Qd1FdXF1s1Esr6QshEzw8gjPfoDdT3BODdH2EHeJUXshKglReyFqLyQFXh8DQwz3M46T6u2o0aWDYZhHVTBZClbyQ_erR3Rue-z-Ff-VlYDsCOgYxjGi-c_uPzB1qSw
Cites_doi 10.1159/000513704
10.1002/jhbp.543
10.3389/fonc.2018.00360
10.1002/bjs.10676
10.1016/j.jamcollsurg.2016.05.019
10.1245/s10434-023-13636-8
10.1001/jamasurg.2020.1973
10.1001/jamasurg.2013.5137
10.1007/s00259-023-06184-6
10.1245/s10434-022-11463-x
10.1038/s41575-020-0310-z
10.1016/j.jhep.2023.03.010
10.1093/annonc/mdy282.146
10.1016/j.jhep.2019.03.013
10.1245/s10434-020-09536-w
10.3389/fonc.2022.896764
10.1001/jamasurg.2013.5168
10.21037/cco.2018.07.03
10.21037/hbsn.2018.03.16
10.1111/liv.15196
10.1186/s40644-019-0234-4
10.1016/j.ejrad.2023.110839
10.3322/caac.21759
10.1002/jso.24720
10.1245/s10434-020-09393-7
10.1200/jco.2022.40.16_suppl.4097
10.1038/s41598-022-12604-8
10.3322/caac.21820
10.1093/annonc/mdq650
10.1002/jso.24381
ContentType Journal Article
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ADTOC
UNPAY
ACYCR
DOI 10.4143/crt.2024.1187
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Unpaywall for CDI: Periodical Content
Unpaywall
Korean Citation Index
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
CrossRef

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: UNPAY
  name: Unpaywall
  url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2005-9256
EndPage 1166
ExternalDocumentID oai_kci_go_kr_ARTI_10766346
10.4143/crt.2024.1187
39930855
10_4143_crt_2024_1187
Genre Validation Study
Multicenter Study
Journal Article
GroupedDBID ---
29B
5-W
53G
8JR
9ZL
AAYXX
ABDBF
ACUHS
ACYCR
ADBBV
AENEX
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
CITATION
DIK
E3Z
EBD
EF.
F5P
HYE
OK1
RPM
TR2
C1A
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ADTOC
UNPAY
ID FETCH-LOGICAL-c2407-a92d1895eff7ffc62bc4f7aefe12d68b1484f25b19ed67ab4e3fc76c76c1b63b3
IEDL.DBID UNPAY
ISSN 1598-2998
2005-9256
IngestDate Thu Oct 16 03:18:03 EDT 2025
Sun Oct 26 03:58:18 EDT 2025
Thu Oct 02 06:31:26 EDT 2025
Sun Oct 19 00:28:50 EDT 2025
Sat Oct 25 05:22:08 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Recurrence
Liver
Cholangiocarcinoma
Multidetector computed tomography
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c2407-a92d1895eff7ffc62bc4f7aefe12d68b1484f25b19ed67ab4e3fc76c76c1b63b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-2932-2367
0000-0002-6898-6617
OpenAccessLink https://proxy.k.utb.cz/login?url=https://doi.org/10.4143/crt.2024.1187
PMID 39930855
PQID 3165415246
PQPubID 23479
PageCount 11
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_10766346
unpaywall_primary_10_4143_crt_2024_1187
proquest_miscellaneous_3165415246
pubmed_primary_39930855
crossref_primary_10_4143_crt_2024_1187
PublicationCentury 2000
PublicationDate 2025-10-01
PublicationDateYYYYMMDD 2025-10-01
PublicationDate_xml – month: 10
  year: 2025
  text: 2025-10-01
  day: 01
PublicationDecade 2020
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
PublicationTitle Cancer research and treatment
PublicationTitleAlternate Cancer Res Treat
PublicationYear 2025
Publisher 대한암학회
Publisher_xml – name: 대한암학회
References ref13
ref12
ref15
ref14
ref31
ref30
Endo (ref4) 2008
ref11
ref33
ref10
ref2
ref1
ref17
ref16
ref19
ref18
Camp (ref24) 2004
Primrose (ref32) 2019
ref23
ref26
ref25
ref20
ref22
ref21
ref28
ref27
ref29
ref8
ref7
ref9
ref3
ref6
ref5
References_xml – start-page: 7252
  volume-title: X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization
  year: 2004
  ident: ref24
– ident: ref28
  doi: 10.1159/000513704
– ident: ref8
  doi: 10.1002/jhbp.543
– ident: ref18
  doi: 10.3389/fonc.2018.00360
– ident: ref10
  doi: 10.1002/bjs.10676
– ident: ref21
  doi: 10.1016/j.jamcollsurg.2016.05.019
– ident: ref23
  doi: 10.1245/s10434-023-13636-8
– ident: ref11
  doi: 10.1001/jamasurg.2020.1973
– ident: ref6
  doi: 10.1001/jamasurg.2013.5137
– ident: ref33
  doi: 10.1007/s00259-023-06184-6
– ident: ref22
  doi: 10.1245/s10434-022-11463-x
– ident: ref30
  doi: 10.1038/s41575-020-0310-z
– ident: ref31
  doi: 10.1016/j.jhep.2023.03.010
– start-page: 663
  volume-title: Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study
  year: 2019
  ident: ref32
– ident: ref12
  doi: 10.1093/annonc/mdy282.146
– ident: ref2
  doi: 10.1016/j.jhep.2019.03.013
– ident: ref13
  doi: 10.1245/s10434-020-09536-w
– ident: ref16
  doi: 10.3389/fonc.2022.896764
– ident: ref26
  doi: 10.1001/jamasurg.2013.5168
– ident: ref20
  doi: 10.21037/cco.2018.07.03
– ident: ref3
  doi: 10.21037/hbsn.2018.03.16
– ident: ref19
  doi: 10.1111/liv.15196
– ident: ref17
  doi: 10.1186/s40644-019-0234-4
– ident: ref29
  doi: 10.1016/j.ejrad.2023.110839
– ident: ref5
  doi: 10.3322/caac.21759
– ident: ref7
  doi: 10.1002/jso.24720
– ident: ref9
  doi: 10.1245/s10434-020-09393-7
– ident: ref14
  doi: 10.1200/jco.2022.40.16_suppl.4097
– ident: ref15
  doi: 10.1038/s41598-022-12604-8
– ident: ref1
  doi: 10.3322/caac.21820
– start-page: 84
  volume-title: Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection
  year: 2008
  ident: ref4
– ident: ref27
  doi: 10.1093/annonc/mdq650
– ident: ref25
  doi: 10.1002/jso.24381
SSID ssj0064371
Score 2.355337
Snippet Purpose We aimed to develop a preoperative risk scoring system to predict early recurrence (ER) of intrahepatic cholangiocarcinoma (ICCA) after resection,...
We aimed to develop a preoperative risk scoring system to predict early recurrence (ER) of intrahepatic cholangiocarcinoma (ICCA) after resection, utilizing...
SourceID nrf
unpaywall
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 1156
SubjectTerms Aged
Bile Duct Neoplasms - pathology
Bile Duct Neoplasms - surgery
Cholangiocarcinoma - diagnostic imaging
Cholangiocarcinoma - mortality
Cholangiocarcinoma - pathology
Cholangiocarcinoma - surgery
Female
Humans
Male
Middle Aged
Neoplasm Recurrence, Local - pathology
Neoplasm Staging
Preoperative Period
Prognosis
Risk Assessment
Risk Factors
Tomography, X-Ray Computed
의학일반
Title Preoperative Prediction Model for Early Recurrence of Intrahepatic Cholangiocarcinoma after Surgical Resection: Development and External Validation Study
URI https://www.ncbi.nlm.nih.gov/pubmed/39930855
https://www.proquest.com/docview/3165415246
https://doi.org/10.4143/crt.2024.1187
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART003254043
UnpaywallVersion publishedVersion
Volume 57
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Cancer Research and Treatment, 2025, 57(4), , pp.1156-1166
journalDatabaseRights – providerCode: PRVEBS
  databaseName: EBSCOhost Academic Search Ultimate
  customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn
  eissn: 2005-9256
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0064371
  issn: 1598-2998
  databaseCode: ABDBF
  dateStart: 20120301
  isFulltext: true
  titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn
  providerName: EBSCOhost
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 2005-9256
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0064371
  issn: 1598-2998
  databaseCode: DIK
  dateStart: 20040101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVERR
  databaseName: KoreaMed Open Access
  customDbUrl:
  eissn: 2005-9256
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0064371
  issn: 1598-2998
  databaseCode: 5-W
  dateStart: 20010101
  isFulltext: true
  titleUrlDefault: https://koreamed.org/journals
  providerName: Korean Association of Medical Journal Editors
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 2005-9256
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0064371
  issn: 1598-2998
  databaseCode: RPM
  dateStart: 20040101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1tb9MwED6xVgL2gfeX8jIZgeBTCkltp-FbN1ZtSJsmoGh8smzHHlVLUmWNpu2f8G-5c9KpvAiQIkWRbMexz7k7-7nnAF6gXyxsLrIotkMZcTkw0ZBbGRmbpW-8oaMb2u84OJR7E_7-WBy3IBqKhVk7v-eoyl_bigCPCe9TWuwN6EqBJncHupPDo9GXwIWaURRByHkbWDUz1OENl-bv9X_SPRtF5f9kVm7CtbpY6PMzPZ-vqZrxTRivOtkgTGb9emn69uIX_sZ_fsUtuNEam2zUSMdtuOKKO3D1oD1OvwvfjypXLlxD_s3wIZ-GMAdGGdLmDO1ZFgiQ2QfalQ9xgaz0bJ82hL86wmJbtkPOcXEyRZ1YYavlN81GlHecfayr8FdlBO4Lzb5laxAlpouc7bYc1OwzugNNdidGyMbzezAZ737a2YvaXA2RJZ8w0lmSx8NMOO9T761MjOU-1c67OMnl0KDXxX0iTJy5XKbacDfwNpV0xQYlZHAfOkVZuIfA8B9shJMZ99Zy6YTWzmhvYpPELhcu6cHL1SyqRUPJodCVoYFWONCKBlrRQPfgOc6xmtmpIhJtup-UalYpdBX2sUqK1haXPXi2kgGFS4vOS3ThyvpUDSjSC-0bKvOgEY7LF5JdRxC_Hry6lJa_9-bRf5d8DNcTyjIcIINPoLOsavcUTZ-l2YLuaPvd9nirXQA_AM2EAX4
linkProvider Unpaywall
linkToUnpaywall http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1tb9MwED6xToLxgfdBedMhEHxKIanjNHyrplUb0qYJKBqfLNuxR9WSVKERGv-Ef8udk07lRYAUKYpkO4598d3Zzz0H8Iz84tQWaR7FdiQjIYcmGgkrI2Pz7JU3fHTD-x1Hx_JgKt6cpqcdiIZjYTbO7wWp8pe2ZsBjIgacFnsLtmVKJncPtqfHJ-OPgQs15yiCkPM2sGrmpMNbLs3f6_-ke7bK2v_JrLwKV5pyqc-_6sViQ9VMrsNk3ckWYTIfNCszsN9-4W_851fcgGudsYnjVjpuwiVX3oLLR91x-m34flK7aula8m-kh2IWwhyQM6QtkOxZDATI-JZ35UNcIFYeD3lD-JNjLLbFPXaOy7MZ6cSaWq0-axxz3nF819RhVUUG94VmX-MGRAl1WeB-x0GNH8gdaLM7ISMbz-_AdLL_fu8g6nI1RJZ9wkjnSRGP8tR5n3lvZWKs8Jl23sVJIUeGvC7hk9TEuStkpo1wQ28zyVdsSEKGu9Arq9LdA6Q12KRO5sJbK6RLtXZGexObJHZF6pI-PF_Polq2lByKXBkeaEUDrXigFQ90H57SHKu5nSkm0eb7WaXmtSJX4ZCqZGRtCdmHJ2sZUPRr8XmJLl3VfFFDjvQi-4bL3G2F4-KFbNcxxK8PLy6k5e-9uf_fJR_ATsJZhgNk8CH0VnXjHpHpszKPO8H_AcojAAw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Preoperative+Prediction+Model+for+Early+Recurrence+of+Intrahepatic+Cholangiocarcinoma+after+Surgical+Resection%3A+Development+and+External+Validation+Study&rft.jtitle=Cancer+research+and+treatment&rft.au=%EA%B9%80%EB%8F%99%ED%99%98&rft.au=%EC%B5%9C%EC%83%81%ED%98%84&rft.au=%EA%B9%80%EC%84%B8%ED%9D%AC&rft.au=%EC%9D%B4%ED%98%95%EC%A7%84&rft.date=2025-10-01&rft.pub=%EB%8C%80%ED%95%9C%EC%95%94%ED%95%99%ED%9A%8C&rft.issn=1598-2998&rft.eissn=2005-9256&rft.spage=1156&rft.epage=1166&rft_id=info:doi/10.4143%2Fcrt.2024.1187&rft.externalDBID=n%2Fa&rft.externalDocID=oai_kci_go_kr_ARTI_10766346
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1598-2998&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1598-2998&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1598-2998&client=summon